-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1) is an important molecule in the field of organic chemistry and has a wide range of applications in the chemical industry.
This molecule can be synthesized through several different methods, and the choice of the synthetic route depends on various factors, including the desired yield, cost, and availability of reagents.
One of the most common methods for synthesizing 12H-dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1) is through a multi-step synthesis route that involves several chemical reactions.
This route typically begins with the synthesis of a precursor molecule, which is then transformed into the desired product through a series of chemical reactions.
The first step in this synthesis route is the synthesis of a bisphosphonate precursor, which is typically achieved through the reaction of a diol with a phosphonate salt in the presence of a strong base.
This reaction forms an intermediate bisphosphonate that can undergo further reactions to form the desired product.
The next step in the synthesis route is the oxidation of the bisphosphonate precursor to form the 6-oxide derivative.
This is typically achieved through the use of an oxidizing agent, such as potassium permanganate or ozone, in the presence of a solvent, such as acetonitrile or DMF.
After the oxidation step, the 6-oxide derivative is typically hydrolyzed to form the hydroxy derivative.
This is typically achieved through the use of a strong acid, such as hydrochloric acid or sulfuric acid, in the presence of a solvent, such as ethyl acetate or toluene.
Finally, the hydroxy derivative is typically converted into the desired product through the use of a reductant, such as lithium aluminum hydride or sodium borohydride, in the presence of a solvent, such as ethanol or THF.
Overall, this synthesis route involves several steps and requires the use of several different reagents, but it is a common and effective method for synthesizing 12H-dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1).
Another synthesis route for 12H-dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (1:1) is through a one-pot synthesis route that involves the simultaneous synthesis of the precursor molecule and the desired product.
This route is more efficient than the multi-step synthesis route, as it reduces the number of steps and the amount of reagents required for the synthesis.
The one-pot synthesis route typically involves the use of a coupling reaction, such as a Suzuki reaction or a Sonogashira reaction, to form the desired product in a single reaction step.
This approach requires the use of specific reagents and conditions, but it can provide a more efficient and cost-effective synthesis method for 12H-dibenzo[d,g][1,3,